059_Header-image_RSNA_20161129_F2R_RAD5719(1)

Radiology Society of
North America

Congress of the Radiology Society of North America (RSNA)

RSNA is the biggest Radiology Conference worldwide. Every year, over 60,000 participants travel to Chicago to participate in this annual conference.

RSNA 2019

RSNA 2019 RSNA 2019

Where in the Dentate Nucleus Is Gadolinium?

A new method detects gadolinium (Gd) in brain tissue on a cellular level: Gd spots were much less and smaller after application of a macrocyclic contrast agent.

Read more
RSNA 2019 RSNA 2019

Breast MRI: DENSE Trial Update 2019

RSNA has chosen the Dutch DENSE trial as one of four high-impact clinical trials in 2019. The study underscores MRI screening for women with dense breasts.

Read more
RSNA 2019 RSNA 2019

Beware of HBP Hypointense Nodules

Nodules without arterial phase hyperenhancement and hypointensity in the HBP mean a higher risk for intrahepatic distant recurrence in treated HCC patients.

Read more
RSNA 2019 RSNA 2019

AI Sharpens Myocardial Scar Diagnosis on MRI

A novel deep learning (DL) based MRI reconstruction algorithm helps to assess myocardial scars.

Read more
RSNA 2019 RSNA 2019

MRI Sequences’ Impact on Assessing Gadolinium Presence

Brain signal intensity ratios are influenced by intensity inhomogeneity correction and flow artifact compensation algorithms.

Read more
RSNA 2019 RSNA 2019

Documentation of Contrast Extravasation Events

Implementing standardized contrast extravasation progress note templates in the electronic medical record allows for consistent event documentation.

Read more
RSNA 2019 RSNA 2019

Breast MRI: Background Parenchymal Enhancement

In breast MRI, quantitative background parenchymal enhancement (BPE) improves risk classification of distant breast cancer recurrence.

Read more
RSNA 2019 RSNA 2019

LBW-Adapted CT Contrast Protocol Saves Dose

Lean body weight (LBW) adapted contrast injection for abdominal CT reduces contrast volume without compromising image quality.

Read more
RSNA 2019 RSNA 2019

MRI Safety Is Everyone’s Business

Radiologists need to make sure MR safety is implemented in a hospital‘s structure and in its employees’ mindset.

Read more
RSNA 2019 RSNA 2019

MRI for HCC Screening and Surveillance

For early HCC detection, the diagnostic performance of MRI is equal to or more convincing than the specificity and sensitivity of CT or ultrasound (US).

Read more
RSNA 2019 RSNA 2019

Value Creation in Radiology

A radiologists’ work intertwines with healthcare systems, physicians, and patients. They all have a different perspective of value in radiology.

Read more
RSNA 2019 RSNA 2019

The Benefits of Primovist®-Enhanced MRI

Gadoxetate disodium (Gd-EOB, Primovist®/Eovist®, 0.025 mmoL/kg) permits better lesion imaging compared to extracellular agents or contrast-enhanced CT.

Read more
Load More

RSNA 2018

Aspects For Choosing an MR Contrast Agent

MR contrast use has shifted almost entirely from linear to macrocyclic agents. “The key point is that...

Read more

How Much Can We Trust AI?

External verification is a key element in dealing with AI-based diagnostic results.

Read more

Decision Support Algorithms in Real Action

Academic institutions proceed in developing machine algorithms for clinical decision support...

Read more

Clinical Decision Support for Better Care

Providing guidelines for radiologists at the point-of-care has measurable impact on compliance...

Read more

CIN Is Much Less Common Than Once Believed

CIN is much less common than previously thought. Most patients have little or no CIN risk...

Read more

Premedicate Fast and Only in Patients with a History of Contrast Reaction

Recommendations for premedicating inpatients with a risk of contrast media reactions have...

Read more

Fast and Accurate Liver Metastases Detection with a Short and Modified MRI Protocol

Detection accuracy of liver metastases with gadoxetate disodium is as good with an...

Read more

Gd-Presence in the Brain: Scientific Evidence and Human Concerns

“Put the entire picture together and do what the patient needs”, recommended Emanuel Kanal...

Read more

GBCAs may be Cleared Through the Glymphatic System

Gadolinium-based contrast agents (GBCAs) detected in the cerebrospinal fluid (CSF) are...

Read more

Gd Presence: Practical Advice for Patients and Physicians

Radiologists should participate in advising patients and referring physicians about the use of...

Read more

Short Primovist

Short Primovist®-MRI in HCC Screening

Read more

Artificial Intelligence: Image the Imperceptible

Artificial Intelligence: Image the Imperceptible

Read more
Load More

Si usted desea informar o reportar un efecto adverso o un reclamo técnico de producto asociado a un producto Bayer, por favor siga las siguientes instrucciones

según la región que le corresponda:

 

MÉXICO 

Información solo para México. Para reportar algún efecto adverso, favor de comunicarse al 800 BAYER SC (2293 772) o enviar un email a farmacovigilancia.mx@bayer.com. Para reportar algún defecto de calidad enviar un email a reclamos.calidadmx@bayer.com.

Toda la información es confidencial y los datos recabados serán conservados en una base de datos únicamente para efectos del reporte.

CONOSUR (Argentina, Bolivia, Chile, Paraguay y Uruguay) PP-PF-RAD-AR-0236-1

Si usted desea reportar un evento adverso o un reclamo técnico de producto asociado a un producto Bayer, por favor dirija sus comentarios ingresando en https://conosur.bayer.com/Contacto

 

© 2023 Bayer

PP-GAD-MX-0028-1
PP-PF-RAD-AR-0286-1
NE: 203300202C0396

  • PP-PF-RAD-ALL-0036-1

Términos de uso

Declaración de privacidad

Si usted desea informar o reportar un efecto adverso o un reclamo técnico de producto asociado a un producto Bayer, por favor siga las siguientes instrucciones

según la región que le corresponda:

 

MÉXICO

Información solo para México. Para reportar algún efecto adverso, favor de comunicarse al 800 BAYER SC (2293 772) o enviar un email a farmacovigilancia.mx@bayer.com. Para reportar algún defecto de calidad enviar un email a reclamos.calidadmx@bayer.com.

Toda la información es confidencial y los datos recabados serán conservados en una base de datos únicamente para efectos del reporte.

 

CONOSUR (Argentina, Bolivia, Chile, Paraguay y Uruguay) PP-PF-RAD-AR-0236-1

Si usted desea reportar un evento adverso o un reclamo técnico de producto asociado a un producto Bayer, por favor dirija sus comentarios ingresando en https://conosur.bayer.com/Contacto

 

© 2023 Bayer

PP-GAD-MX-0028-1
PP-PF-RAD-AR-0286-1
NE: 203300202C0396

Bayer-logo-white